A
Agilent Technologies Inc.
Healthcare
12/16/2013
Presented
| Date | 12/11/2013 |
| Price | $39.59 |
| Market Cap | $18.30B |
| Ent Value | $18.33B |
| P/E Ratio | 37.43x |
| Book Value | $9.02 |
| Div Yield | 0.9% |
| Shares O/S | 462.45M |
| Ave Daily Vol | 3,774,600 |
| Short Int | 0.89% |
Current
| Price | $144.58 |
| Market Cap | $41.54B |
| Agilent Technologies, Inc. provides bio-analytical and electronic measurement solutions and services to the life sciences, chemical analysis, diagnostics and genomics, communications, and electronics industries worldwide. The company’s Life Sciences segment offers liquid chromatography systems, columns, and components; liquid chromatography mass spectrometry systems; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; nucleic acid solutions; and nuclear magnetic resonance, magnetic resonance imaging, and X-ray diffraction systems. Its Chemical Analysis segment provides gas chromatography systems, columns, and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; inductively coupled plasma optical emission spectrometry instruments; molecular spectroscopy instruments; software and data systems; and vacuum pumps and measurement technologies. The company’s Diagnostics and Genomics segment offers immunohistochemistry, in situ hybridization, hematoxylin and eosin staining, special staining, DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, and DNA methylation and gene expression profiling, as well as automated gel electrophoresis-based sample analysis systems. Its Electronic Measurement segment provides electronic measurement instruments and systems, software design tools, and related services used in the design, development, manufacture, installation, deployment, and operation of electronics equipment and microscopy products. This segment’s products include communications and general purpose test products. Agilent Technologies, Inc. sells its products through direct sales representatives; and distributors, resellers, manufacturer's representatives, telesales, and electronic commerce. The company was founded in 1999 and is headquartered in Santa Clara, California. |
Please note, this stock split on 11/03/2014 at a ratio of 1398/1000. The presented data has been updated to account for the change, however, the text of note may refer to data based on the original presented price of $55.34.
Highlights
The presenter is long shares of Agilent (A), and believes the company’s shares are “organically worth at least $70, and potentially worth as much as $75-$80 following the planned spin-off of Life Sciences, which could be acquired or merged with another company in the industry.” In addition to the current share price (~$55) not reflecting the optionality of the spin-off, he believes the Street is underestimating A’s earnings power and that the stock is under-owned by mutual fund complexes who used to hold substantial positions. A’s fundamentals are better than comparable testing and measurement companies, yet shares trade at a discount to peers on both sides of its business.
◆Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.
◆Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.